Repeat Breast-Conserving Surgery Versus Salvage Mastectomy for Ipsilateral Breast Tumour Recurrence After Breast-Conserving Surgery in Breast Cancer Patients: A Meta-Analysis

被引:10
作者
Mo, Caiqin [1 ]
Ruan, Weihong [2 ]
Lin, Junyu [3 ]
Chen, Huaying [3 ]
Chen, Xiangjin [1 ]
机构
[1] Fujian Med Univ, Dept Breast & Thyroid Surg, Affiliated Hosp 1, Fujian, Peoples R China
[2] Tradit Chinese Hosp Xiamen, Dept Gen Surg, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Med Coll 1, Fujian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
meta-analysis; repeat breast-conserving surgery; salvage mastectomy; ipsilateral breast tumor recurrence; breast cancer; ISOLATED LOCOREGIONAL RECURRENCE; 2ND CONSERVATIVE TREATMENT; LOCAL RECURRENCE; PROGNOSTIC-FACTORS; RADIATION-THERAPY; INTERSTITIAL BRACHYTHERAPY; DISTANT METASTASES; MAMMARY RECURRENCE; LUMPECTOMY; IRRADIATION;
D O I
10.3389/fonc.2021.734719
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Salvage mastectomy (SM) is the standard surgery for ipsilateral breast tumour recurrence (IBTR). However, whether repeat breast-conserving surgery (RBCS) is an alternative method remains unclear. We performed a meta-analysis to compare the effects of RBCS and SM after IBTR for breast-conserving surgery (BCS).Methods: We searched PubMed, Cochrane, Wiley Online and Embase for controlled studies comparing RBCS and SM after IBTR for BCS (published between 1993 and 2019, published in English). Our main endpoints were the secondary local recurrence rate (SLRR), distant metastasis rate (DMR) and overall survival (OS). We used a random-effects model or fixed-effects model for data pooling.Results: Fifteen of the 424 eligible studies were ultimately included, and all studies were retrospective cohort studies (n=2532 participants). 1) SLRR: The SLRR of RBCS was higher than SM (pooled relative rate (pRR) = 1.87, 95% CI 1.22 - 2.86, P=0.004). Stratified analysis was performed according to whether radiotherapy was performed after salvage surgery (radiotherapy group: 2ndRT, no radiotherapy group: no-2ndRT), and the following results were revealed: pRR=0.43 (95% CI 0.20-0.95, P=0.04) for group 2ndRT; and pRR=2.30 (95% CI 1.72-3.06, P < 0.00001) for group no-2ndRT. These results showed that the main cause of heterogeneity was salvage radiotherapy. 2) DMR: No significant difference in the DMR was observed between RBCS and SM (pRR = 0.61, 95% CI 0.37 - 1.01, P=0.05). 3) OS: No significant difference in OS was observed between RBCS and SM (pRR=0.65, 95% CI 0.39 - 1.08, P=0.10).Conclusions: The SLRR of RBCS was higher than SM for ITBR after BCS, but survival was not affected. RBCS may be used as an alternative for IBTR patients after BCS with strict control for several indications, such as tumor size, recurrence interval and biological behavior, and attaching importance to subsequent salvage radiotherapy and systematic therapy.
引用
收藏
页数:10
相关论文
共 54 条
  • [1] PROGNOSIS FOLLOWING SALVAGE MASTECTOMY FOR RECURRENCE IN THE BREAST AFTER CONSERVATIVE SURGERY AND RADIATION-THERAPY FOR EARLY-STAGE BREAST-CANCER
    ABNER, AL
    RECHT, A
    EBERLEIN, T
    COME, S
    SHULMAN, L
    HAYES, D
    CONNOLLY, JL
    SCHNITT, SJ
    SILVER, B
    HARRIS, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) : 44 - 48
  • [2] Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
    Aebi, Stefan
    Gelber, Shari
    Anderson, Stewart J.
    Lang, Istvan
    Robidoux, Andre
    Martin, Miguel
    Nortier, Johan W. R.
    Paterson, Alexander H. G.
    Rimawi, Mothaffar F.
    Canada, Jose Manuel Baena
    Thuerlimann, Beat
    Murray, Elizabeth
    Mamounas, Eleftherios P.
    Geyer, Charles E., Jr.
    Price, Karen N.
    Coates, Alan S.
    Gelber, Richard D.
    Rastogi, Priya
    Wolmark, Norman
    Wapnir, Irene L.
    [J]. LANCET ONCOLOGY, 2014, 15 (02) : 156 - 163
  • [3] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [4] Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation
    Alpert, TE
    Kuerer, HM
    Arthur, DW
    Lannin, DR
    Haffty, BG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03): : 845 - 851
  • [5] Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial
    Arthur, Douglas W.
    Winter, Kathryn A.
    Kuerer, Henry M.
    Haffty, Bruce
    Cuttino, Laurie
    Todor, Dorin A.
    Anne, Pramila Rani
    Anderson, Penny
    Woodward, Wendy A.
    McCormick, Beryl
    Cheston, Sally
    Sahijdak, Walter M.
    Canaday, Daniel
    Brown, Doris R.
    Currey, Adam
    Fisher, Christine M.
    Jagsi, Reshma
    Moughan, Jennifer
    White, Julia R.
    [J]. JAMA ONCOLOGY, 2020, 6 (01) : 75 - 82
  • [6] NRG Oncologye-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence
    Arthur, Douglas W.
    Winter, Kathryn A.
    Kuerer, Henry M.
    Haffty, Bruce G.
    Cuttino, Laurie W.
    Todor, Dorin A.
    Simone, Nicole L.
    Hayes, Shelly B.
    Woodward, Wendy A.
    McCormick, Beryl
    Cohen, Randi J.
    Sahijdak, Walter M.
    Canaday, Daniel J.
    Brown, Doris R.
    Currey, Adam D.
    Fisher, Christine M.
    Jagsi, Reshma
    White, Julia
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (05): : 1028 - 1035
  • [7] Treatment of Recurrent Breast Cancer Following Breast Conserving Surgery
    Burger, Amy E. E.
    Pain, Simon J.
    Peley, Gabor
    [J]. BREAST JOURNAL, 2013, 19 (03) : 310 - 318
  • [8] The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer
    Chadha, Manjeet
    Feldman, Sheldon
    Boolbol, Susan
    Wang, Lin
    Harrison, Louis B.
    [J]. BRACHYTHERAPY, 2008, 7 (01) : 22 - 28
  • [9] The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence
    Chen, Steven L.
    Martinez, Steve R.
    [J]. AMERICAN JOURNAL OF SURGERY, 2008, 196 (04) : 495 - 499
  • [10] Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer
    Dalberg, K
    Mattsson, A
    Sandelin, K
    Rutqvist, LE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (01) : 69 - 78